News
Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following the FDA's move to grant traditional approval to the drug that treats individuals with Alzheimer’s disease. The CMS had previously announced this would be the case and released more details on coverage.
Posted 7/7/2023